The Prevention and Treatment of Intestinal Failure-associated Liver Disease in Neonates and Children (Q37881465)

24 August 2017

1 reference

title

The prevention and treatment of intestinal failure-associated liver disease in neonates and children (English)

1 reference

24 August 2017

The Prevention and Treatment of Intestinal Failure-associated Liver Disease in Neonates and Children (English)

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

3 December 2024

1 reference

Deepika Nehra

1

1 reference

24 August 2017

Mark Puder

3

1 reference

24 August 2017

Erica M. Fallon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21621695

3 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21621695

3 December 2024

publication date

15 April 2011

1 reference

full work available at URL

24 August 2017

https://api.elsevier.com/content/article/PII:S0039610911000119?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

https://api.elsevier.com/content/article/PII:S0039610911000119?httpAccept=text/plain

3 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Surgical Clinics of North America

3 December 2024

published in

1 reference

24 August 2017

volume

91

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

543-563

1 reference

Causes and management of intestinal failure in children

24 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Overview of pediatric short bowel syndrome

3 December 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Pediatric intestinal failure: nutrition, pharmacologic, and surgical approaches

3 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Parenteral nutrition-associated liver complications in children

3 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Total parenteral nutrition-associated liver disease

3 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Liver Complications of Pediatric Parenteral Nutrition—Epidemiology

3 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience.

3 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis.

3 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition

3 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Prevalence of life-threatening complications in pediatric patients affected by intestinal failure

3 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes

3 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

New approaches to understanding the etiology and treatment of total parenteral nutrition-associated cholestasis

3 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors

3 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease

3 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Hyperbilirubinemia in neonates associated with total parenteral nutrition

3 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Predicting liver failure in parenteral nutrition-dependent short bowel syndrome of infancy.

3 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Parenteral nutrition-associated cholestasis related to parental care

3 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Total parenteral nutrition induced liver pathology: an autopsy series of 24 newborn cases

3 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Relationship between biopsy-proven parenteralnutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome

3 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Total parenteral nutrition-associated cholestasis: clinical and histopathologic correlation

3 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Development of fat emulsions

3 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Essential fatty acids: biochemistry, physiology and pathology

3 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Effects of fat emulsions with different fatty acid composition on plasma and hepatic lipids in rats receiving total parenteral nutrition

3 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Lipid entrapment and cellular changes in the rat myocard, lung and liver after long-term parenteral nutrition with lipid emulsion. A light microscopic and ultrastructural study

3 December 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Effects of intravenous lipid as a source of energy in parenteral nutrition associated hepatic dysfunction and lidocaine elimination: a study using isolated rat liver perfusion

3 December 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition

3 December 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Safe and efficacious prolonged use of an olive oil-based lipid emulsion (ClinOleic) in chronic intestinal failure

3 December 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Comparison of soybean oil- and olive oil-based lipid emulsions on hepatobiliary function and serum triacylglycerols level during realimentation

3 December 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil.

3 December 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Omega-3 fatty acids and liver disease

3 December 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid.

3 December 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Effects of dietary supplementation with fish oil on prostanoid metabolism during acute coronary occlusion with or without reperfusion in diet-induced hypercholesterolemic rabbits

3 December 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Current clinical applications of omega-6 and omega-3 fatty acids

3 December 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease

3 December 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Impact of arachidonic versus eicosapentaenoic acid on exotonin-induced lung vascular leakage: relation to 4-series versus 5-series leukotriene generation

3 December 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis

3 December 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR.

3 December 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition

3 December 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management

3 December 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease

3 December 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury.

3 December 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience.

3 December 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients

3 December 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Parenteral fish oil as monotherapy for patients with parenteral nutrition-associated liver disease

3 December 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome

3 December 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease

3 December 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Omegaven for the treatment of parenteral nutrition associated liver disease: a case study

3 December 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease

3 December 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids).

3 December 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid

3 December 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula

3 December 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Arachidonic acid status correlates with first year growth in preterm infants

3 December 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia

3 December 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Parenteral fish oil as monotherapy improves lipid profiles in children with parenteral nutrition-associated liver disease

3 December 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Variable hypocoagulant effect of fish oil intake in humans: modulation of fibrinogen level and thrombin generation

3 December 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Safe practices for parenteral nutrition

3 December 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure

3 December 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Nutritional management of infants with short bowel syndrome

3 December 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children

3 December 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

The inadequacy of the essential fatty acid content of present preterm feeds.

3 December 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Omega-3 Fatty acids and neural development to 2 years of age: do we know enough for dietary recommendations?

3 December 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Innovative parenteral and enteral nutrition therapy for intestinal failure

3 December 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

The metabolic response to surgery in neonates.

3 December 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Burn Management in Children

3 December 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Use of cyclic parenteral nutrition in infants less than 6 months of age

3 December 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

The association of cyclic parenteral nutrition and decreased incidence of cholestatic liver disease in patients with gastroschisis

3 December 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Dispositions of di- and mono-(2-ethylhexyl) phthalate in newborn infants subjected to exchange transfusions

3 December 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Use of di(2-ethylhexyl)phthalate-containing infusion systems increases the risk for cholestasis

3 December 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000

3 December 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Contribution of the raw material to the aluminum contamination in parenterals.

3 December 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Aluminum exposure from pediatric parenteral nutrition: meeting the new FDA regulation

3 December 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Steatohepatitis: a tale of two "hits"?

3 December 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Subcutaneous vitamin E ameliorates liver injury in anin vivo model of steatocholestasis

3 December 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Some new insights in intestinal failure-associated liver disease

3 December 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Bile acid conjugation pattern in the isolated perfused rat liver during infusion of an amino acid formulation

3 December 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Effect of taurine on total parenteral nutrition-associated cholestasis

3 December 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Taurine deficiency in the severe hepatic dysfunction complicating total parenteral nutrition

3 December 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Taurine concentrations in plasma, blood cells, and urine of children undergoing long-term total parenteral nutrition

3 December 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Plasma amino acid concentrations in children receiving long-term parenteral nutrition

3 December 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Parenteral nutrition-associated cholestasis in neonates: multivariate analysis of the potential protective effect of taurine

3 December 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Effect of taurine supplementation on hepatic function during short-term parenteral nutrition in the premature infant

3 December 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Serum zinc, copper, and selenium concentrations in preterm infants receiving enteral nutrition or parental nutrition supplemented with zinc and copper

3 December 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Meeting zinc and copper intake requirements in the parenterally fed preterm and full-term infant

3 December 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Clinical zinc deficiency during zinc-supplemented parenteral nutrition.

3 December 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Clinical spectrum of zinc deficiency in pediatric patients receiving total parenteral nutrition (TPN)

3 December 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Short bowel syndrome in pediatric patients

3 December 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Management of short bowel syndrome: avoidance of total parenteral nutrition

3 December 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Basal nutrition promotes human intestinal epithelial (Caco-2) proliferation, brush border enzyme activity, and motility

3 December 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

A controlled comparison of continuous versus intermittent feeding in the treatment of infants with intestinal disease

3 December 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Effect of enteral feeding on hepatic steatosis induced by total parenteral nutrition

3 December 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Prevention of liver failure in parenteral nutrition-dependent children with short bowel syndrome

3 December 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Predicting the duration of dependence on parenteral nutrition after neonatal intestinal resection

3 December 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

The role of enteral nutrition in the reversal of parenteral nutrition-associated liver dysfunction in infants

3 December 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Effects of non-nutritive sucking and oral stimulation on breastfeeding rates for preterm, low birth weight infants: a randomized clinical trial

3 December 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders

3 December 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome

3 December 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Epidermal growth factor alters the bax:bcl-w ratio following massive small bowel resection

3 December 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Effect of breast milk and weaning on epithelial growth of the small intestine in humans

3 December 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Reducing parenteral requirement in children with short bowel syndrome: impact of an amino acid-based complete infant formula

3 December 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

New and emerging therapies for short bowel syndrome in children

3 December 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Effect of high percentage medium-chain triglyceride diet on mucosal adaptation following massive bowel resection in rats

3 December 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Dietary lipids influence intestinal adaptation after massive bowel resection

3 December 2024

114

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Effects of monomeric and polymeric diets on small intestine following massive resection

3 December 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Pediatric enteral nutrition

3 December 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Nutrition support of infants with short bowel syndrome

3 December 2024

117

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study

3 December 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Parenteral nutrition-associated cholestasis in preterm neonates: evaluation of ursodeoxycholic acid treatment

3 December 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis.

3 December 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Tauroursodeoxycholic acid (TUDCA) in the prevention of total parenteral nutrition-associated liver disease

3 December 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Use of cholecystokinin-octapeptide for the prevention of parenteral nutrition-associated cholestasis

3 December 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Failure of cholecystokinin-octapeptide to prevent TPN-associated gallstone disease

3 December 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Ursodiol in patients with parenteral nutrition-associated cholestasis.

3 December 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Review article: drug hepatotoxicity

3 December 2024

125

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Acute and clinically relevant drug-induced liver injury: a population based case-control study.

3 December 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver

3 December 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

3 December 2024

Drug-induced cholestasis

129

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

3 December 2024

Drug-induced cholestasis

130

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition

3 December 2024

131

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Intestinal permeability and bacterial translocation are uncoupled after small bowel resection

3 December 2024

132

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Prospective study of indwelling central venous catheter-related complications in children with broviac or clampless valved catheters

3 December 2024

133

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Use of maximal sterile barrier precautions and/or antimicrobial-coated catheters to reduce the risk of central venous catheter-related bloodstream infection.

3 December 2024

135

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients

3 December 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia

3 December 2024

137

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Antibiotic lock technique: a review of the literature

3 December 2024

138

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children

3 December 2024

139

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Use of ethanol locks to prevent recurrent central line sepsis

3 December 2024

140

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial.

3 December 2024

141

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Use of an ethanol lock to prevent catheter-related infections in children with short bowel syndrome

3 December 2024

142

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial

3 December 2024

143

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease

3 December 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Short-bowel syndrome in children and adults

3 December 2024

145

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

A possible beneficial effect of metronidazole in reducing TPN-associated liver function derangements

3 December 2024

146

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

An analysis of factors contributing to the development of total parenteral nutrition-induced cholestasis

3 December 2024

147

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

TPN-associated hyperbilirubinemia: a common problem in newborn surgical patients

3 December 2024

148

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Surgical intervention in the setting of parenteral nutrition–associated cholestasis may exacerbate liver injury

3 December 2024

149

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Intestinal loop lengthening—A technique for increasing small intestinal length

3 December 2024

151

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Longitudinal Intestinal Lengthening and Tailoring: Results in 20 Children

3 December 2024

152

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

First report of the international serial transverse enteroplasty data registry: indications, efficacy, and complications.

3 December 2024

153

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Serial transverse enteroplasty (STEP): A novel bowel lengthening procedure

3 December 2024

154

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Current perspectives on pediatric intestinal transplantation.

3 December 2024

155

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Isolated liver transplantation in infants with end-stage liver disease associated with short bowel syndrome.

3 December 2024

157

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Isolated liver transplant in infants with short bowel syndrome: insights into outcomes and prognostic factors

3 December 2024

158

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

Ischemic hepatitis is a risk factor for progression of liver disease associated with parenteral nutrition in intestinal failure

3 December 2024

159

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.02.003

3 December 2024

Identifiers

1 reference

24 August 2017

1 reference